This inventor holds 1 USPTO granted patent. Top assignee: Kirin Beer Kabushiki Kaisha. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Hirohi Ohashi: Innovator in Urea Derivatives
Introduction
Hirohi Ohashi is a notable inventor based in Gunma, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on urea derivatives. His research focuses on developing compounds that can effectively inhibit the CCR-3 receptor, which is implicated in various diseases.
Latest Patents
Hirohi Ohashi holds a patent for "Urea derivatives as inhibitors for CCR-3 receptor." This patent describes how urea and thiourea derivatives can inhibit the cell function of the chemokine receptor CCR-3. These compounds offer a promising approach for treating a range of diseases thought to be mediated by this receptor. The synthesis of these useful urea and thiourea derivatives can be achieved through both liquid and solid phase synthesis protocols. He has 1 patent to his name.
Career Highlights
Ohashi is currently associated with Kirin Beer Kabushiki Kaisha, where he continues to explore innovative solutions in his field. His work has garnered attention for its potential applications in therapeutic settings.
Collaborations
He has collaborated with notable colleagues, including Michael Hocker and Janak Padia, to advance his research and development efforts.
Conclusion
Hirohi Ohashi's contributions to the field of medicinal chemistry, particularly through his patent on urea derivatives, highlight his role as an innovator. His work has the potential to impact the treatment of diseases mediated by the CCR-3 receptor significantly.